2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Fertility Preservation: Options for cancer patients before, during, and after treatment.
Fertility preservation in cancer patients is a critical consideration, as certain cancer treatments, particularly chemotherapy and radiation, can impair reproductive function. Before starting cancer therapy, patients of reproductive age may be given the option to preserve their fertility to ensure that they can have children in the future. Methods such as egg or sperm freezing, embryo preservation, or ovarian tissue cryopreservation are common approaches used to safeguard fertility. The choice of preservation method depends on factors like the patient's age, the type of cancer, and the anticipated treatment regimen. It is important for oncologists to address fertility preservation options early in the treatment process, as this decision can have long-lasting effects on the patient’s future quality of life. Providing counseling and support about fertility options ensures that patients are informed and empowered to make decisions that align with their personal and family goals, while also receiving the necessary cancer treatment.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China